Cicilline, Nadler Introduce Bill to Lower Prescription Drug Costs
November 18, 2019
November 18, 2019
WASHINGTON, Nov. 18 -- Rep. Jerrold Nadler, D-New York, issued the following news release:
Today, House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) to prohibit pharmaceutical companies from engaging in anticompetitive "product hopping." The bill is scheduled to be marked up in the Judiciary Committee . . .
Today, House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) to prohibit pharmaceutical companies from engaging in anticompetitive "product hopping." The bill is scheduled to be marked up in the Judiciary Committee . . .